Organon

YTD

ALL

Trade Organon 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About OGN

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

CEO

Joseph T. Morrissey

CEOJoseph T. Morrissey

Employees

10,000

Employees10,000

Headquarters

Jersey City, New Jersey

HeadquartersJersey City, New Jersey

Founded

2020

Founded2020

Employees

10,000

Employees10,000

OGN Key Statistics

Market cap

2.25B

Market cap2.25B

Price-Earnings ratio

4.22

Price-Earnings ratio4.22

Dividend yield

4.19%

Dividend yield4.19%

Average volume

6.02M

Average volume6.02M

High today

$8.69

High today$8.69

Low today

$8.43

Low today$8.43

Open price

$8.47

Open price$8.47

Volume

1.72M

Volume1.72M

52 Week high

$17.23

52 Week high$17.23

52 Week low

$6.18

52 Week low$6.18

Stock Snapshot

As of today, Organon(OGN) shares are valued at $8.67. The company's market cap stands at 2.25B, with a P/E ratio of 4.22 and a dividend yield of 4.2%.

On 2026-01-14, Organon(OGN) stock traded between a low of $8.43 and a high of $8.69. Shares are currently priced at $8.67, which is +2.8% above the low and -0.2% below the high.

Organon(OGN) shares are trading with a volume of 1.72M, against a daily average of 6.02M.

In the last year, Organon(OGN) shares hit a 52-week high of $17.23 and a 52-week low of $6.18.

Analyst ratings

44%

of 9 ratings

Buy

11.1%

Hold

44.4%

Sell

44.4%

People also own

Based on the portfolios of people who own OGN. This list is generated using Robinhood data, and it’s not a recommendation.